WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that consolidated net income from continuing operations attributable to Safeguard common shareholders in the second quarter was $146.2 million, or $1.20 per share, compared with a net loss of $7.5 million, or $0.06 per share, in the same period of 2008.
